Skip to main content
PACIFIC EDGE LIMITED logo

PACIFIC EDGE LIMITED — Investor Relations & Filings

Ticker · PEB ISIN · NZPEBE0002S1 LEI · 9845007EDCF068FFEA12 ASX Professional, scientific and technical activities
Open in API
Filings indexed 747 across all filing types
Latest filing 2022-01-18 Board/Management Inform…
Country NZ New Zealand
Listing ASX PEB

About PACIFIC EDGE LIMITED

https://www.pacificedgedx.com/

Pacific Edge Limited is a cancer diagnostics company specializing in the development and commercialization of non-invasive molecular diagnostic tests. The company's primary product suite, Cxbladder, utilizes advanced mRNA biomarker technology to detect and monitor bladder cancer from urine samples. These genomic tests are designed to assist clinicians in the evaluation of patients presenting with hematuria and in the ongoing surveillance of patients previously diagnosed with the disease. By providing high sensitivity and negative predictive value, the Cxbladder suite helps to accurately rule out urothelial carcinoma, potentially reducing the requirement for invasive clinical procedures such as cystoscopy. The company focuses on integrating its diagnostic tools into standard clinical pathways to improve patient outcomes and healthcare efficiency.

Recent filings

Filing Released Lang Actions
Dr Peter Meintjes commences as Pacific Edge Chief Executive 2 pages 200.8KB
Board/Management Information Classification · 100% confidence The document is a company announcement dated 19 January 2022, announcing the commencement of Dr Peter Meintjes as the new Chief Executive Officer of Pacific Edge. It includes background information about the company and its products but does not contain any financial data, regulatory filings, or detailed reports. The document is relatively short (4264 characters) and serves as a management change announcement. Therefore, it fits the category of Board/Management Information (MANG).
2022-01-18 English
Capital Change Notice
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Pacific Edge Limited Capital Change Notice' and details the issuance of ordinary shares, including the number of shares issued, issue price, and authority for the issue. It specifies that shares were issued on exercise of options and includes issuer information, dates, and contact details. The content focuses exclusively on a capital change event rather than financial performance, management changes, or regulatory compliance. The document length is 3140 characters, which is relatively short but contains substantive details about the capital change rather than just an announcement of a report. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2022-01-13 English
Capital Change Notice - NZX 2 pages 277.9KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Pacific Edge Limited Capital Change Notice' and details the issuance of ordinary shares, including the number of shares issued, issue price, and authority for the issue. It specifies that shares were issued on exercise of options and includes issuer information, dates, and contact details. The content focuses on a capital change event rather than a full financial report or earnings release. The document length is 3140 characters, which is relatively short and consistent with a capital change announcement. Therefore, the document fits the category of Share Issue/Capital Change (SHA).
2022-01-12 English
Application for quotation of securities - PEB 6 pages 28.0KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary shares, including numbers, issue dates, and pricing. It is a regulatory announcement about new securities being quoted, not a financial report or earnings release. It fits the category of Share Issue/Capital Change as it concerns new shares being issued and quoted following option exercises.
2022-01-12 English
ASX Appendix 2A
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary shares. It includes specifics about the number of securities, issue dates, and pricing. This is a formal announcement related to capital changes, specifically the issuance and quotation of new shares resulting from option exercises. It is not a financial report, earnings release, or management discussion, but rather a capital market update about securities issuance and quotation. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and content confirm it is not a brief announcement of a report or a regulatory filing fallback.
2021-12-16 English
Capital Change Notice
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Pacific Edge Limited Capital Change Notice' and details the issuance of ordinary shares, including the number of shares issued, prices, and authority for the issue. It specifies the capital change details such as the number of shares issued, exercise price, and the total number of shares after issuance. There is no financial performance data, earnings information, or management discussion. The document is a formal announcement of a change in the company's capital structure, specifically the issuance of new shares. This fits the definition of a Share Issue/Capital Change announcement (SHA). The document length is 2873 characters, which is consistent with a concise announcement rather than a full report.
2021-12-15 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.